AWA
TXG icon

Authentikos Wealth Advisory’s 10x Genomics TXG Stock Holding History

Authentikos Wealth Advisory’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20
Closed -$825 – 545
2023
Q3 		$825 Buy
+20
New +$1.04K ﹤0.01% 525

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Authentikos Wealth Advisory's TXG Position: Q4 2023 in Review

Authentikos Wealth Advisory sold out of 10x Genomics (TXG) in Q4 2023, closing a stake of 20 shares — an estimated $825 sold.

Authentikos Wealth Advisory first reported a position in TXG in Q3 2023 and held it in 1 quarter. The position peaked at $825 in Q3 2023. 275 funds tracked by Wall St. Rank hold TXG as of Q4 2023.

  • Authentikos Wealth Advisory reported no remaining 10x Genomics position as of Q4 2023 after selling out during the quarter.
  • Authentikos Wealth Advisory sold 20 10x Genomics shares in Q4 2023, an estimated $825.
  • Authentikos Wealth Advisory first reported a position in 10x Genomics in Q3 2023 and held it in 1 quarter.
  • Authentikos Wealth Advisory's 10x Genomics position peaked at $825 in Q3 2023.
  • 275 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2023.

Based on Authentikos Wealth Advisory's 13F filing for Q4 2023, filed 30 Jan 2024.